Vogrig, Alberto <br/><br/>
Central nervous system complications associated with immune checkpoint inhibitors.  [electronic resource] 

 -  Journal of neurology, neurosurgery, and psychiatry  07 2020 
 - 772-778 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-330X 
<br/><br/><label>Standard No.: </label>10.1136/jnnp-2020-323055  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>Antineoplastic Agents, Immunological--adverse effects<br/>Confusion--chemically induced<br/>Databases, Factual<br/>Female<br/>Humans<br/>Ipilimumab--adverse effects<br/>Male<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Nivolumab--adverse effects<br/>Parkinsonian Disorders--chemically induced